Á lódáil...
RAS and BRAF in metastatic colorectal cancer management
The treatment of metastatic colorectal cancer (mCRC) has been further refined with the development of monoclonal antibodies, cetuximab and panitumumab, towards the epidermal growth factor receptor (EGFR). Anti-EGFR therapy has afforded improved survival in those with wild-type RAS mCRC but provides...
Na minha lista:
| Foilsithe in: | J Gastrointest Oncol |
|---|---|
| Main Authors: | , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
AME Publishing Company
2016
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5056249/ https://ncbi.nlm.nih.gov/pubmed/27747083 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo.2016.06.12 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|